RXRX
Recursion Pharmaceuticals Inc
Mentions (24Hr)
0.00% Today
Reddit Posts
insider trading made 500k filed with SEC should I buy puts?
Nvidia $NVDA has invested $50 million in Recursion Pharmaceuticals $RXRX, an AI drug discovery platform, which has sent its stock up by 78%
RXRX is my pick for the next big thing in AI, what are you betting on?
RXRX short interest only 11%, but a squeeze still playing out…
Insider Trading Weekly Update #028: $DASH CEO, CFO Dump Company Stock, Largest Trades Overall + By Market Sector From The Past Week
RXRX had prior support turned resistance and now we are coming back to that resistance again 29.50 area, just reclaimed 20 SMA will watch for the follow-through move and push over 29.50 and 37.00
RXRX had prior support turned resistance and now we are coming back to that resistance again 29.50 area, just reclaimed 20 SMA will watch for the follow-through move and push over 29.50 and 37.00
Mentions
Been holding 10k RXRX since like $6 it hit $3 AH after Jensen flushed that turd from Nvidias books. What do I do?
Absolutely RXRX, my target price is minimum 12$
RXRX is such a piece of shit hooooly
#TLDR --- **Ticker:** RXRX **Direction:** Up **Prognosis:** Long Shares / Sell $3 Puts (Targeting $5+) **Catalysts:** REC 4881 results (75% reduction in polyps) & High Short Interest **Risk:** High cash burn (but runway extends to 2027) **OP's Status:** Transfusing blood by day, bagholding bio-pharm by night
"Nvidia picked a stake in RxRx in 2023. " The stake as of their last 13f is $37,607,051. "Nothing has been delivered yet " Their trial results haven't been very good, their pipeline isn't much and at one point they had to curtail a number of things to slow the pace they were going through cash. "Was this just vendor financing" Some of NVDA's investments in recent years have been meaningful, some are not. This is the latter. Long while ago someone asked what people would short and while I didn't short it (should have), my answer was RXRX. It's getting to the point of being too obliterated to bet against and with a 33% short interest any decent news could send it higher but it's not demonstrated a good track record as a public company (and if a similar company was willing to sell to them, what did that say about the future? The stock is about -50% from where that deal happened.)
If you are saying this aloud it means you are probably considering it as an investment. TBH I’ve done pretty good with it. Probably above average returns. But I DCA companies all the time. Right now I flipped it all into RCL, NFLX, and RXRX for a high volatility play. I have hedged my holdings downside so it is capping my return, but a one off release will let it skyrocket when bullishness finally returns.
I don't think you know what high beta means if you're trying to refer to the tech stocks crashing today, SNDK and crew aren't remotely near the top 100 list of highest beta stocks. The only high beta stocks popular with retail are SHOP and RXRX
RECURSION PHARMACEUTICALS (RXRX) will be the big winner!
Swing trading (RXRX, SOUN, GDRX, KOS, considering MARA) and a couple others
RXRX has been bleeding for months and that data platform narrative hasn't saved anyone yet. The squeeze thesis feels forced when the stock can't even hold basic support levels - I'd need to see some actual institutional buying before believing this isn't just another biotech pump attempt.
**This should be SQUEEZED!** **Recursion Pharmaceuticals Inc's (RXRX.NaE)** short interest as a percent of float has risen 7.8% since its last report. According to exchange reported data, there are now **165.73 million shares sold short**, which is 33.73% of all regular shares that are available for trading. Based on its trading volume, **it would take traders 6.14 days to cover their short positions on average**
The short interest is increasing in the stocks RXRX, AI, JACK, MBLY, UAA, LCID, PLAY , etc. what's going on in this increased short interest? Any ideas?
What do you think about RXRX for Monday?
Recursion Pharmaceuticals (RXRX) went up by 7.59% today. I just did some research. There is around 33.56% short interest in this stock i.e., 165.7 million shares approximately as on 31 December 2026. The short sellers should have had a tough time on Thursday. Around 36million shares volume traded on Thursday. This is interesting with that huge short interest.
RXRX stock looks interesting. AI play and pipeline is loaded as well.
i think you are right for the wrong reasons. climate change, natural resource depletion aren't real problems for Investments: climate change isn't that big of a dial for companies (it is for animals habitat and poor nations but not for the sep). natural resource depletion will be a problem in another 100 year maybe the elefant in the room is ai. and in particular AGI/ASI. if we (as of humanity) succesfully build an asi the entire economic sistema of the world will see change drastically. ASI is the most important technology that humans can create, more consequential than fire, agricolture, or electricity. a world whit an asi is a world that dosn't need human work, and where incredible new technology is discovered autonomously at speed unimaginable. the right thing to do is simple by ai stock. my opinion of particular stocks: the best: GOOGLE (50% of my portfolio): has modles, tpu, fsd... very good: TSMC, INTELL, ASML good but not perfect: BROADCOM, NVIDIA, AMAZON, MICROSOFT, TESLA, AMD, MU more risky but potentially interesting: RXRX, OKLO, [z.ai](http://z.ai/), mimimax (and probably a lot more) and i hope for openai, antropi, x1 robbotica, figure and unitree IPOs S&P will probably still be decent but a lot of companies will fail. and more importantly work will be a memory of the past so better have a huge portfolio or live in a country that offers UBI.
so i dont get in further trouble... how about my next money maker RXRX... better!?
IMO, RXRX is a very Cathie Wood stock. It conceptually sounds appealing/exciting theme but when you look at ARKG over the last 5 years, you can see the "hype years" and you can see the years where healthcare is struggling and fundamentals matter. In the latter (2021, 2022, 2024) , the fund has been at the bottom of the category. When you look at the long-term? 3YR/5YR/10YR the fund is at or near the bottom of the category. IMO, if you have one of the greatest growth investing periods that I've ever invested in and the 5 year chart is just a continual erosion, there's something amatter. Recursion merged with peer Exscientia in August 2024. If this was such a compelling area, why would that company sell itself way off the highs? The merger hasn't seemed to help RXRX either. In terms of trials: REC-994 (Cerebral Cavernous Malformation): Recursion's lead candidate failed to demonstrate convincing efficacy in Phase 2. While it met the primary goal of safety, long-term extension data showed no promising trends in MRI or functional outcomes, becoming indistinguishable from natural history. REC-2282 (Neurofibromatosis Type 2): Development was halted after preliminary Phase 2/3 data from the POPLAR-NF2 trial showed limited tumor shrinkage and clinical activity. While the 40mg dose passed a futility threshold, the totality of the data did not justify further investment. REC-3964 (C. difficile Infection): Despite being the first new chemical entity developed through the "RecursionOS" platform, this Phase 2 program was discontinued in May 2025. The company cited a strategic decision to focus on other areas rather than clinical setbacks. REC-4881 (Solid Tumors): A pause was announced for this drug specifically targeting solid tumors, though it remains in development for other indications like FAP (Familial Adenomatous Polyposis) where it has shown more positive results. The company has been around for a bit now and when you look at the pipeline, there is one thing in phase 2, nothing in phase 3, the rest are all phase 1/pre clinical. Looking at a discussion on r/biotech: "Think it came up in another thread, but they just don't give the vibe they know what they're doing in clinical development. It's hard to say it exactly. But somehow they don't talk like they understand how hard it is to actually get something to market and what needs to be done to make that happen." (https://www.reddit.com/r/biotech/comments/1f8icsi/with_few_specifics_recursion_underwhelms_with/ - another thread: https://www.reddit.com/r/biotech/comments/1klmsi1/what_do_you_guys_think_of_recursion/) Also, I wasn't even aware the CEO stepped down a couple mo ago. Again, not saying this is a zero and don't want to be harsh but I just think this is one of those things where the results haven't matched the hype. The stock is 33% short (which says something) so any good news and could get a short squeeze. There is some cash to get through the year and there is a pipeline, but nothing in that pipeline is in stage 3/is seeming to generate that much excitement. IMO, AI around genetic testing (TEM, GH, former ILMN spin off/source of controversy GRAL, NTRA) has been an investment theme that has delivered a lot more than AI drug discovery - at least at this point.
There is Recursion RXRX in the middle and prior to this (Already partnered with Nvidia)
Fair enough! Cathie's biotech plays have been high risk/high reward for a while now. Glad it's working out for you so far—hopefully $RXRX keeps that momentum going.
God I hope my RXRX gets sucked into this for their data set
Who else is patiently waiting for RXRX to make its move in 2026?
I've already mentioned one of them. I bought 2,500@4.22 of RXRX. That's 0.2% of my portfolio, but a fun one that I believe will be lucrative. A couple of other people have followed me on that one, but it's not something you should put a lot of capital into, since it's speculative (but important, because of its AI-driven drug discovery platform, and their apparently successful drug candidate that could get fast tracked by the FDA in H1 2026). I don't think we'll post a portfolio here, since the whole point is to benefit the group that actually does the work, and there will be a lot of it. Good Luck, Durham
RXRX. OPEN is so last year.
Superlatives time. Biggest doodoo stock of the year? My entry: $RXRX YOUR TURN!
RXRX IVVD and NOKIA. ....and SLV lol
Look into IVVD and RXRX, and NOKIA all undervalued.
RXRX; in spite of what Kramer has to say.
RKLB, ASTS, IonQ, Ginkgo Bioworks (DNA), RXRX, ESS Tech (GWH), maybe LUNR, NuScale. Google is my base, IBM too - like the biggest quantum play. I will maybe add TMC.
AI medicine, because they are going to run out of hyped up stocks: RXRX ABCL SDGR ABSI
It doesn't take much to make RKLB or ASTS rocket up 30% for a few weeks before gravity pulls them back. So you can play chicken with boxing those gains before they tech escape velocity and stay up. But what fun is 30% when you can double? POET, RXRX, INVZ.
Haha RXRX gapping up because they made a drug for a disease called FAP
What does RXRX actually do?
bought 15k of RXRX, don't let me down regards!
|Category|Winner|Insight| |:-|:-|:-| |Business Model|**ABCL**|Capital-light, partner-centric| |Data/Tech Moat|**RXRX**|Hardest-to-replicate dataset| |Revenue Visibility|**ABCL**|Milestones + royalties| |Long-term Upside|**RXRX**|If platform works → giant outcome| |Risk Level|**RXRX (high)**|Most speculative| |Financial Strength|**ABCL**|More runway, less burn|
Why not RXRX? RXRX also does AI drug discovery space
Unfortunately I work in this industry and RXRX is a 0. No drug company has demonstrated meaningful ROI from AI. Their compounds in trials are mostly in licensed or repurposed from other companies and programs and are not actually generated from their “AI” platform. Companies like this live and die by trial results and I am far from convinced that any of theirs will succeed.
RXRX is the most moonshotty moonshot I have. AI pharma drug discovery pure play. If it works it'll be explosive.
There are even companies that do it, look at RXRX — they use AI to help with computing potential molecule/receptor binding pairs to find novel compounds with medical significance
!banbet $RXRX $5.80 3w
Lol RXRX is still a thing? I made a quick buck off it a year ago from $6 to mid $9 and then sold it and it tanked again.
Pretty funny if any regards here think they know better than NVIDIA... who basically control the stock market now. No idea what RXRX does but the prolly gonna cure cancer or some shit by January.
I just want out of my RXRX honestly I'm so tired I could've gotten out at 7:15 the other day but I forgot to check it 😩😭
Data infrastructure: VRT Satellites: GSAT and PL No brainer: JPM Covid buy: MPC Next up? Entered ABSI and RXRX today on the heavy heavy dips, entered NRIX back in April. Biotech / drug discovery has been walloped, but these 3 have things going for them. High risk obviously / not investment advice
We gonna know if NVIDIA is the $50m investor for QSI on today. If it is, the weekends is gonna be a blast like RXRX had back in 2023.
That happened in March, almost as soon as I started. I rolled down, often below my basis at the time of selling the call. I was able to collect enough to bring premiums to bring my basis down and still be profitable. I used those premiums to buy other stocks. I did get caught on a couple but not badly. And one of them (RXRX) took a months of grinding, but it's up to positive territory now, basis wise. One was not recoverable - WOLF. But now I know to avoid those. I'm at 40% RoC for RXRX but if I was assigned on Monday, I'd only make 5% net profit on the entire chain that goes back to Feb. I'm at 19% RoC on SOUN and if I was assigned right now, I'd make 45% net profit.
Loaded RXRX heavy. It’s long hold.
Can’t wait for RXRX earnings Wed morning! Holding 8k shares….
RXRX earnings on Wednesday.
RLAY and RXRX pharma and AI. Also AI.
The high volume tea kettle that is RXRX is about to blow. It's been climbing and building up steam that last month on basically no news. Which means once a PR comes out .... 👀
get in for BMNR, RXRX, and dnut earnings
If thats MIRA the bio stock, i dont touch those or even look at those, especially if i cant do options on it(i use wealthsimple and dont have the option to trade options on it) I know this will sound stupid but the only person online i listen to about Bio pharma is the pharma bro himself shkreli....hate him or love him, but if anyone know pharma its him...i watched his video on RXRX and he was talking about how most of their drugs werent actually dicovered by AI and how he'd actually worked on half of them like a decade ago...and to be fair hes been right about quantum as well, he shorted them all at the top and has made 5×+ his money on hit. Quantum is shit right now, insanely over priced and non of them actually make money. The CEO of RGTI actually said their 5 years out from firing up their quantum computer. Theres a few i like and a few im dont...BBAI is in a weird spot for me i like up but their insanely volatile...id be comfortable with a long ass call like 2027-2028 5-6$ call for around 1.00-1.60 premium ....LAES has also been fucking with me mentally, i kept wanting to get in around around 5-5.50 on a long ass 5c but im too late now so i might avoid completely or buy so puts at its highs. Two DCTs im holding calls on for shits and giggles is CAN 3 .50c 01/21 2028 for 1.70 and BTBT 4c 01/15 2027 1.97 And idk if youd call RZLV one but i got a couple calls for that one cause i think reddit can pump her once more lol I also have a dnut call but thats because i actually like dnut and bought it before filthy reddit got its hands on it, now i get to watch it go up 100% then down then back up with no intentions of selling it, its a 3.50c 01/21 2028 1.52
RXRX is worth the speculation. If they’re successful, it’s a trillion dollar company.
What stocks you into? I’m thinking a good lineup right now is: NVTS SRV BULL LUNR RXRX WRD These are all very cheap, well-funded, and supported by huge funders who are experts in a related space (except for BULL which is just another well known broker)
Need to learn buying near bottom. Not at the top. Research RXRX my friend.
Only a matter of time before this sub pumps RXRX. If you buy now you won't be my exit liquidity at $15-$20/share
Add $RXRX to your watchlist for AI biotech model training and AI-drug discovery: * They have the best proprietary biological and chemical datasets in the world * 65 petabytes spanning phenomics, transcriptomics, InVivomics, proteomics, ADME, and de-identified patient data
RXRX, hopefully will boom soon
Nah the repeating structure here in the first four are suspicious af. Humans don't talk like this right? **Symbotic (SYM)** – automating warehouses for Walmart and others. If logistics go full robot, this one flies. **Recursion Pharma (RXRX)** – AI drug discovery backed by Nvidia. One pipeline success = game over. **SoundHound AI (SOUN)** – voice AI for drive-thrus, cars, devices. If embedded voice takes over, they’re first in line. **IonQ (IONQ)** – pure play quantum computing. Still early, but if quantum hits, this rips.
If you’re going to play this game, buy Recursion (RXRX)
Any DD on $RXRX basically AI X BIOTECH … big names holding 👀
on the sharing question I have got BRK.B, META, LULU, RXRX so far, please keep going if you want to contribute with us!
anybody playing RXRX?
My RXRX call from Friday is up 100%😭😭😭😭
I would like to thank the folks pumping RXRX today. You saved my marriage<3
Do you think RXRX pumps any time soon? They're due to release news before EOY 2025 right?
Long on RXRX and RLAY. biotech and AI trading around book value easy money.
$QSI and Nvidia reveal as the $50m investor is gonna fucking rip it like RXRX did back then
$QSI all fucking in, shit is blowing up on threads and people are saying its like RXRX cause Nvidia was the secret $50m investor similarly
Hey man, great analysis. There’s a growing case that NVIDIA was the undisclosed institutional investor behind Quantum-Si’s $50 million private placement announced on July 3, 2025. The structure of the deal is such that of one institutional investor purchasing roughly 29.9 million shares and “common-stock equivalents” at $1.67 per share. So basically imo, the reason why this NVIDIA rumors even came about was because of its strong parallel to RXRX situation back in 2023. QSI started with a collaboration in 2024 with NVIDIA which show they already had a foothold there. Considering how QSI semiconductor is such an important feature of their platform (proteus) set to be their biggest game changer product at end of this year as a prototype, a reveal of NVIDIA would not come as a huge surprise. Basically, this $50m investment in Quantum-Si KIND of closely mirror the $50 million investment NVIDIA made in Recursion Pharmaceuticals (RXRX) in July 2023, where it acquired about 7.7 million shares, or roughly 4 % of the company. In Recursion’s case, the stake size was large enough to be strategic but small enough to stay below the 5 % beneficial-ownership threshold that requires a Schedule 13D filing. The same pattern fits Quantum-Si’s situation: no 13D or 13G was filed by NVIDIA, implying the investor’s effective ownership was likely capped below 5 %, perhaps around 3 or 4 %, achieved through pre-funded warrants or convertible instruments. (Note that on the announcement, it very explicitly mentioned COMMON STOCK EQUIVALENTS as well which most people would have likely missed. [Quantum-Si Incorporated Announces Pricing of $50 Million Registered Direct Offering of Common Stock | Quantum-Si](https://www.quantum-si.com/press-releases/quantum-si-incorporated-announces-pricing-of-50-million-registered-direct-offering-of-common-stock-2/?utm_source=chatgpt.com) I do not expect 10 USD/stock to be too high if NVIDIA is actually the singular full investor who achieve the ownership via this method. However, on the technical aspects, I agree that 10 USD could be high, but this is likely not the case imo. If you noticed in the recent 2 weeks, the volume has been rather "insane". Over 25million on normal days and over 15 million even on bad days for a SMALL CAP stock no less. I'm not sure if this was because of my post 2 weeks ago that caught people or institutions attention. In any case, I would just preface by saying that 10 USD/stock is high on a technical standpoint (you are right on this). However, there is a very good chance it will go close to it on the "innovative hype" alone coupled with NVIDIA reveal (if this was actually true). Note that there is no other public company on the same level as Quantum-Si dealing with proteomics with such a strong balance sheet and near-term catalyst in November. I will not be surprised if this makes a huge move soon with such monster volume.
RXRX is a Ponzi Scheme period. Sold at a loss
Everyone manipulating pump and dump ponzi like RXRX should be sent into prison. This shit will never get to 7 like yesterday
Look at that dumb ass RXRX red candle at 8:30am. They even don’t wanna pretend. This is a classic pump and dump ponzi
Squeeze baby squeeze RXRX 🚀 🌝
Guys I'm all in on RXRX seems like a solid bet any comments on that?
RXRX is the worst pump and dump ponzi. At least other projects pumped high enough. This shit is down 80% last 5 years without any momentum.
Take a look at how criminal RXRX chart is for today. Spectacular bagholders recruiting event. They lured you to buy at 7. This, apparently won’t get to 7 again in the near future
RXRX is doing that fake pump today. Sec should take a look at this criminal company
# MODS WOULDN'T LET ME POST SHIT BUT I PRESENT TO YOU QUANTUM SI If you’ve been following me the past two weeks, you already know I called Quantum-Si at $1.35. Now it’s sitting close $3, literally doubled, and people are still acting surprised (talking smack with a firm that has over $300mil in cash with insane catalyst in November). I told everyone to load up before the November events, but even I didn’t expect this kind of insane volume this week. We’re talking **> 20 MILLION SHARES** traded on some days, and it’s not because of “quantum hype.” This thing is moving completely on its own. On days when Rigetti and IonQ are down, QSI is up double digits. When they bounce 8 percent, QSI rips 14 percent. It’s decoupled, period. The $50 million financing changed everything. That cash gave them room to scale and instantly made the stock investable for funds that used to ignore it. Add in the Nvidia rumor, which isn’t confirmed but is lighting up momentum (SAID TO BE 14 NOVEMBER AS THE REVEAL OR EARLIER DEPENDING ON THE REQUIRED LAST FILING DATE), and an early earnings call set for November 4, and you’ve got a perfect setup. Then two weeks later, they have an analyst day in New York on November 19. Two catalysts back to back. Yea, I get it that QSI isn’t a quantum computing stock like Rigetti or IonQ. BUT this is proteomics, single-molecule protein sequencing, completely different lane. That’s why it’s running when the rest of the quantum names are trading sideways or down. It’s not trading on the theme anymore and people are literally seeing it for what it is worth now. It’s trading on its own fundamentals and speculation that the November events are going to blow expectations out of the water. Bottom line, QSI is flying because it’s graduating from a speculative small-cap to a legitimate growth story with real money behind it. The flow, the setup, the timing and everything is lining up. Don’t say you weren’t told lol. Right now, it is trading close to $3 and I almost can guarantee with how much trade volume it is seeing without any news, this is going to GRADUATE OUT OF PENNY LAND by next week at this rate. It is honestly so strange that there is so much volume and it further affirms to my suspicions that it may most likely be NVIDIA as the secret investor. Just like how $RXRX went almost triple with NVIDIA announcement. Fun fact, just know that QSI had a collaboration with NVIDIA back then. We all know that NVIDIA wants a pie of almost every industry and let's just say NVIDIA has not publicly stated an investment in a proteomic public firm yet but ALL signs are pointing strongly to QSI as the partner reveal in November (potential leak) which is the only reason why there is such a MONSTER surge these few days. With November coming, this could literally go to $10 and above.
# MODS WOULDN'T LET ME POST SHIT BUT I PRESENT TO YOU QUANTUM SI If you’ve been following me the past two weeks, you already know I called Quantum-Si at $1.35. Now it’s sitting close $3, literally doubled, and people are still acting surprised (talking smack with a firm that has over $300mil in cash with insane catalyst in November). I told everyone to load up before the November events, but even I didn’t expect this kind of insane volume this week. We’re talking **> 20 MILLION SHARES** traded on some days, and it’s not because of “quantum hype.” This thing is moving completely on its own. On days when Rigetti and IonQ are down, QSI is up double digits. When they bounce 8 percent, QSI rips 14 percent. It’s decoupled, period. The $50 million financing changed everything. That cash gave them room to scale and instantly made the stock investable for funds that used to ignore it. Add in the Nvidia rumor, which isn’t confirmed but is lighting up momentum (SAID TO BE 14 NOVEMBER AS THE REVEAL OR EARLIER DEPENDING ON THE REQUIRED LAST FILING DATE), and an early earnings call set for November 4, and you’ve got a perfect setup. Then two weeks later, they have an analyst day in New York on November 19. Two catalysts back to back. Yea, I get it that QSI isn’t a quantum computing stock like Rigetti or IonQ. BUT this is proteomics, single-molecule protein sequencing, completely different lane. That’s why it’s running when the rest of the quantum names are trading sideways or down. It’s not trading on the theme anymore and people are literally seeing it for what it is worth now. It’s trading on its own fundamentals and speculation that the November events are going to blow expectations out of the water. Bottom line, QSI is flying because it’s graduating from a speculative small-cap to a legitimate growth story with real money behind it. The flow, the setup, the timing and everything is lining up. Don’t say you weren’t told lol. Right now, it is trading close to $3 and I almost can guarantee with how much trade volume it is seeing without any news, this is going to GRADUATE OUT OF PENNY LAND by next week at this rate. It is honestly so strange that there is so much volume and it further affirms to my suspicions that it may most likely be NVIDIA as the secret investor. Just like how $RXRX went almost triple with NVIDIA announcement. Fun fact, just know that QSI had a collaboration with NVIDIA back then. We all know that NVIDIA wants a pie of almost every industry and let's just say NVIDIA has not publicly stated an investment in a proteomic public firm yet but ALL signs are pointing strongly to QSI as the partner reveal in November (potential leak) which is the only reason why there is such a MONSTER surge these few days. With November coming, this could literally go to $10 and above.
# MODS WOULDN'T LET ME POST SHIT BUT I PRESENT TO YOU QUANTUM SI If you’ve been following me the past two weeks, you already know I called Quantum-Si at $1.35. Now it’s sitting close $3, literally doubled, and people are still acting surprised (talking smack with a firm that has over $300mil in cash with insane catalyst in November). I told everyone to load up before the November events, but even I didn’t expect this kind of insane volume this week. We’re talking **> 20 MILLION SHARES** traded on some days, and it’s not because of “quantum hype.” This thing is moving completely on its own. On days when Rigetti and IonQ are down, QSI is up double digits. When they bounce 8 percent, QSI rips 14 percent. It’s decoupled, period. The $50 million financing changed everything. That cash gave them room to scale and instantly made the stock investable for funds that used to ignore it. Add in the Nvidia rumor, which isn’t confirmed but is lighting up momentum (SAID TO BE 14 NOVEMBER AS THE REVEAL OR EARLIER DEPENDING ON THE REQUIRED LAST FILING DATE), and an early earnings call set for November 4, and you’ve got a perfect setup. Then two weeks later, they have an analyst day in New York on November 19. Two catalysts back to back. Yea, I get it that QSI isn’t a quantum computing stock like Rigetti or IonQ. BUT this is proteomics, single-molecule protein sequencing, completely different lane. That’s why it’s running when the rest of the quantum names are trading sideways or down. It’s not trading on the theme anymore and people are literally seeing it for what it is worth now. It’s trading on its own fundamentals and speculation that the November events are going to blow expectations out of the water. Bottom line, QSI is flying because it’s graduating from a speculative small-cap to a legitimate growth story with real money behind it. The flow, the setup, the timing and everything is lining up. Don’t say you weren’t told lol. Right now, it is trading close to $3 and I almost can guarantee with how much trade volume it is seeing without any news, this is going to GRADUATE OUT OF PENNY LAND by next week at this rate. It is honestly so strange that there is so much volume and it further affirms to my suspicions that it may most likely be NVIDIA as the secret investor. Just like how $RXRX went almost triple with NVIDIA announcement. Fun fact, just know that QSI had a collaboration with NVIDIA back then. We all know that NVIDIA wants a pie of almost every industry and let's just say NVIDIA has not publicly stated an investment in a proteomic public firm yet but ALL signs are pointing strongly to QSI as the partner reveal in November (potential leak) which is the only reason why there is such a MONSTER surge these few days. With November coming, this could literally go to $10 and above.
RGTI OKLO ASTS RKLB QBTS CLSK SMR RXRX BKSY NKLR been doing good for me but like all I wish I had the extra cash to yeet at them